Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Oxymetazoline recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Oxymetazoline (53 total). Check the affected lots below.

Most common reason: cGMP deviation (44 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Oxymetazoline. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Oxymetazoline recalls on record

none so far in 2026; 53 on record, newest first
Class III · Low risk

SinuFrin Decongestant

Sub-potent Drug

Ongoing Other Neilmed Pharmaceuticals Inc NDC 13709-325-01 D-0569-2024
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0629-2022
Class II · Moderate risk

Maximum Strength Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-989-10 D-0628-2022
Class II · Moderate risk

Sinus Severe

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-696-10 D-0627-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 49035-388-10 D-0626-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 36800-388-10 D-0625-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0624-2022
Class II · Moderate risk

No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41163-703-10 D-0623-2022
Class II · Moderate risk

No Drip Nasal Decongestant

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 21130-801-10 D-0622-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11822-6319-1 D-0621-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0620-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 41250-388-10 D-0619-2022
Class II · Moderate risk

Nasal Spray Decongestant

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 30142-388-10 D-0617-2022
Class II · Moderate risk

Maxiumum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 55910-623-10 D-0616-2022
Class II · Moderate risk

No Drip Nasal Mist

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 59779-388-10 D-0615-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 72288-388-10 D-0614-2022
Class II · Moderate risk

Maximum Strength No Drip Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 72288-388-10 D-0613-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 36800-907-10 D-0612-2022
Class II · Moderate risk

Severe Congestion Nasal Spray

CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.

Terminated cGMP deviation Perrigo Company PLC NDC 11673-935-10 D-0611-2022